Zobrazeno 1 - 10
of 514
pro vyhledávání: '"antifibrotic agents"'
Autor:
Sun J; College of Pharmacy & Graduate School of Pharmaceutical Sciences, Ewha Womans University, 52 Ewhayeodae-gil, Seodaemun-gu, Seoul 03760, Republic of Korea., Kim S; College of Pharmacy & Graduate School of Pharmaceutical Sciences, Ewha Womans University, 52 Ewhayeodae-gil, Seodaemun-gu, Seoul 03760, Republic of Korea., Park S; College of Pharmacy & Graduate School of Pharmaceutical Sciences, Ewha Womans University, 52 Ewhayeodae-gil, Seodaemun-gu, Seoul 03760, Republic of Korea., Hwang S; College of Pharmacy & Graduate School of Pharmaceutical Sciences, Ewha Womans University, 52 Ewhayeodae-gil, Seodaemun-gu, Seoul 03760, Republic of Korea., Sheen N; College of Pharmacy & Graduate School of Pharmaceutical Sciences, Ewha Womans University, 52 Ewhayeodae-gil, Seodaemun-gu, Seoul 03760, Republic of Korea., Kim S; College of Pharmacy & Graduate School of Pharmaceutical Sciences, Ewha Womans University, 52 Ewhayeodae-gil, Seodaemun-gu, Seoul 03760, Republic of Korea., Kwon Y; College of Pharmacy & Graduate School of Pharmaceutical Sciences, Ewha Womans University, 52 Ewhayeodae-gil, Seodaemun-gu, Seoul 03760, Republic of Korea. Electronic address: ykwon@ewha.ac.kr., Ryu JS; College of Pharmacy & Graduate School of Pharmaceutical Sciences, Ewha Womans University, 52 Ewhayeodae-gil, Seodaemun-gu, Seoul 03760, Republic of Korea. Electronic address: ryuj@ewha.ac.kr.
Publikováno v:
Bioorganic & medicinal chemistry [Bioorg Med Chem] 2024 Oct 01; Vol. 112, pp. 117881. Date of Electronic Publication: 2024 Aug 16.
Autor:
Asami-Noyama M; Department of Respiratory Medicine and Infectious Disease, Graduate School of Medicine, Yamaguchi University, 1-1-1 Minami-Kogushi, Ube, Yamaguchi, 755-8505, Japan. Electronic address: noyamama@yamaguchi-u.ac.jp., Hamada K; Department of Respiratory Medicine and Infectious Disease, Graduate School of Medicine, Yamaguchi University, 1-1-1 Minami-Kogushi, Ube, Yamaguchi, 755-8505, Japan; Department of Systems Bioinformatics, Yamaguchi University Graduate School of Medicine, Ube, Yamaguchi, 755-8505, Japan., Asai Y; Department of Systems Bioinformatics, Yamaguchi University Graduate School of Medicine, Ube, Yamaguchi, 755-8505, Japan; AI Systems Medicine Research and Training Center (AISMEC), Graduate School of Medicine, Yamaguchi University and Yamaguchi University Hospital, Ube, Yamaguchi, 755-8505, Japan., Abe T; AI Systems Medicine Research and Training Center (AISMEC), Graduate School of Medicine, Yamaguchi University and Yamaguchi University Hospital, Ube, Yamaguchi, 755-8505, Japan., Yonezawa K; Department of Respiratory Medicine and Infectious Disease, Graduate School of Medicine, Yamaguchi University, 1-1-1 Minami-Kogushi, Ube, Yamaguchi, 755-8505, Japan., Watanabe M; Department of Respiratory Medicine and Infectious Disease, Graduate School of Medicine, Yamaguchi University, 1-1-1 Minami-Kogushi, Ube, Yamaguchi, 755-8505, Japan., Hisamoto Y; Department of Respiratory Medicine and Infectious Disease, Graduate School of Medicine, Yamaguchi University, 1-1-1 Minami-Kogushi, Ube, Yamaguchi, 755-8505, Japan., Murakawa K; Department of Respiratory Medicine and Infectious Disease, Graduate School of Medicine, Yamaguchi University, 1-1-1 Minami-Kogushi, Ube, Yamaguchi, 755-8505, Japan., Fukatsu A; Department of Respiratory Medicine and Infectious Disease, Graduate School of Medicine, Yamaguchi University, 1-1-1 Minami-Kogushi, Ube, Yamaguchi, 755-8505, Japan., Matsuda K; Department of Respiratory Medicine and Infectious Disease, Graduate School of Medicine, Yamaguchi University, 1-1-1 Minami-Kogushi, Ube, Yamaguchi, 755-8505, Japan., Ohata S; Department of Respiratory Medicine and Infectious Disease, Graduate School of Medicine, Yamaguchi University, 1-1-1 Minami-Kogushi, Ube, Yamaguchi, 755-8505, Japan., Suetake R; Department of Respiratory Medicine and Infectious Disease, Graduate School of Medicine, Yamaguchi University, 1-1-1 Minami-Kogushi, Ube, Yamaguchi, 755-8505, Japan., Murata Y; Department of Respiratory Medicine and Infectious Disease, Graduate School of Medicine, Yamaguchi University, 1-1-1 Minami-Kogushi, Ube, Yamaguchi, 755-8505, Japan., Yamaji Y; Department of Respiratory Medicine and Infectious Disease, Graduate School of Medicine, Yamaguchi University, 1-1-1 Minami-Kogushi, Ube, Yamaguchi, 755-8505, Japan., Oishi K; Department of Respiratory Medicine and Infectious Disease, Graduate School of Medicine, Yamaguchi University, 1-1-1 Minami-Kogushi, Ube, Yamaguchi, 755-8505, Japan., Edakuni N; Department of Respiratory Medicine and Infectious Disease, Graduate School of Medicine, Yamaguchi University, 1-1-1 Minami-Kogushi, Ube, Yamaguchi, 755-8505, Japan., Hirano T; Department of Respiratory Medicine and Infectious Disease, Graduate School of Medicine, Yamaguchi University, 1-1-1 Minami-Kogushi, Ube, Yamaguchi, 755-8505, Japan., Kakugawa T; Department of Pulmonology and Gerontology, Graduate School of Medicine, Yamaguchi University, 1-1-1 Minami-Kogushi, Ube, Yamaguchi, 755-8554, Japan., Matsunaga K; Department of Respiratory Medicine and Infectious Disease, Graduate School of Medicine, Yamaguchi University, 1-1-1 Minami-Kogushi, Ube, Yamaguchi, 755-8505, Japan.
Publikováno v:
Respiratory investigation [Respir Investig] 2024 Nov; Vol. 62 (6), pp. 1124-1131. Date of Electronic Publication: 2024 Oct 02.
Autor:
Söllner JF; Boehringer Ingelheim Pharma GmbH and Co. KG, Biberach, Germany. julia.soellner@boehringer-ingelheim.com., Bentink S; Staburo GmbH, Munich, Germany., Hesslinger C; Boehringer Ingelheim Pharma GmbH and Co. KG, Biberach, Germany., Leonard TB; Boehringer Ingelheim Pharmaceuticals, Inc., Ridgefield, CT, USA., Neely ML; Duke Clinical Research Institute, Durham, NC, USA.; Duke University Medical Center, Durham, NC, USA., Patel NM; Boehringer Ingelheim Pharmaceuticals, Inc., Ridgefield, CT, USA., Schlange T; Boehringer Ingelheim Pharma GmbH and Co. KG, Biberach, Germany., Todd JL; Duke Clinical Research Institute, Durham, NC, USA.; Duke University Medical Center, Durham, NC, USA., Vinisko R; Boehringer Ingelheim Pharmaceuticals, Inc., Ridgefield, CT, USA., Salisbury ML; Vanderbilt University Medical Center, Nashville, TN, USA.
Publikováno v:
Lung [Lung] 2024 Oct; Vol. 202 (5), pp. 595-599. Date of Electronic Publication: 2024 Sep 06.
Autor:
Shu Y; Department of Respiratory and Critical Care Medicine, West China School of Medicine and West China Hospital, Sichuan University, Chengdu, China., He L; Clinical Trial Center, National Medical Products Administration Key Laboratory for Clinical Research and Evaluation of Innovative Drugs, West China Hospital, Sichuan University, Chengdu, China., Liu C; Department of Respiratory and Critical Care Medicine, West China Hospital, Sichuan University, Chengdu, China. Electronic address: taosen666999@163.com.
Publikováno v:
International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases [Int J Infect Dis] 2024 Oct; Vol. 147, pp. 107193. Date of Electronic Publication: 2024 Jul 31.
Autor:
Xu H; Department of Biostatistics and Health Data Science and., Hui SL; Department of Biostatistics and Health Data Science and., Lee JS; University of Colorado Denver Anschutz Medical Campus, Aurora, Colorado; and., Zhang Z; AbbVie Inc., North Chicago, Illinois., Boente RD; Division of Pulmonary, Critical Care, Sleep and Occupational Medicine, School of Medicine, Indiana University, Indianapolis, Indiana.
Publikováno v:
Annals of the American Thoracic Society [Ann Am Thorac Soc] 2024 Oct; Vol. 21 (10), pp. 1407-1415.
Autor:
Lahane GP; Department of Pharmacy, Birla Institute of Technology and Sciences (BITS) Pilani, Hyderabad, Telangana, India., Dhar A; Department of Pharmacy, Birla Institute of Technology and Sciences (BITS) Pilani, Hyderabad, Telangana, India., Bhat A; Centre for Molecular Biology, Central University of Jammu, Samba, Jammu and Kashmir, India.
Publikováno v:
Journal of biochemical and molecular toxicology [J Biochem Mol Toxicol] 2024 Aug; Vol. 38 (8), pp. e23795.
Autor:
Aribindi K; Department of Internal Medicine, Division of Pulmonary, Critical Care & Sleep Medicine, University of California Davis, School of Medicine, Sacramento, CA, USA.; Department of Medicine, Department of Veterans Affairs Northern California Health Care System, Mather, CA, USA., Liu GY; Department of Internal Medicine, Division of Pulmonary, Critical Care & Sleep Medicine, University of California Davis, School of Medicine, Sacramento, CA, USA., Albertson TE; Department of Internal Medicine, Division of Pulmonary, Critical Care & Sleep Medicine, University of California Davis, School of Medicine, Sacramento, CA, USA.; Department of Medicine, Department of Veterans Affairs Northern California Health Care System, Mather, CA, USA.
Publikováno v:
Expert review of clinical pharmacology [Expert Rev Clin Pharmacol] 2024 Sep; Vol. 17 (9), pp. 817-835. Date of Electronic Publication: 2024 Aug 27.
Autor:
Duarte AC; Hospital Garcia de Orta, Unidade Local de Saúde Almada-Seixal., Marques Gomes C; Centro Hospitalar Universitário de São João, Unidade Local de Saúde de São João., Correia M; Hospital de Braga, Unidade Local de Saúde de Braga., Mendes B; Hospitais da Universidade de Coimbra, Unidade Local de Saúde de Coimbra., Mazeda C; Hospital Infante D. Pedro, Unidade Local de Saúde da Região de Aveiro., Guimarães F; Unidade Local de Saúde do Alto Minho., Abelha-Aleixo J; Hospital de Vila Nova de Gaia, Unidade Local de Saúde de Gaia/Espinho., Guerra M; Centro Hospitalar Universitário Cova da Beira, Unidade Local de Saúde da Cova da Beira., Pereira da Costa R; Hospital Santa Maria, Unidade Local de Saúde Santa Maria, Lisbon Academic Medical Center (CAML)., Meirinhos T; Unidade Local de Saúde do Tâmega e Sousa., Santos MJ; Hospital Garcia de Orta, Unidade Local de Saúde Almada-Seixal.
Publikováno v:
ARP rheumatology [ARP Rheumatol] 2024 Jul-Sep; Vol. 3 (3), pp. 182-188.
Autor:
Hozumi H; Second Division, Department of Internal Medicine, Hamamatsu University School of Medicine, 1-20-1 Handayama Higashiku, Hamamatsu, 431-3192, Japan. hozumi@hama-med.ac.jp., Miyashita K; Second Division, Department of Internal Medicine, Hamamatsu University School of Medicine, 1-20-1 Handayama Higashiku, Hamamatsu, 431-3192, Japan., Nakatani E; Research Support Center, Shizuoka General Hospital, 4-27-1 Kita Ando Aoi-ku, Shizuoka, 420-8527, Japan., Inoue Y; Second Division, Department of Internal Medicine, Hamamatsu University School of Medicine, 1-20-1 Handayama Higashiku, Hamamatsu, 431-3192, Japan., Yasui H; Second Division, Department of Internal Medicine, Hamamatsu University School of Medicine, 1-20-1 Handayama Higashiku, Hamamatsu, 431-3192, Japan., Suzuki Y; Second Division, Department of Internal Medicine, Hamamatsu University School of Medicine, 1-20-1 Handayama Higashiku, Hamamatsu, 431-3192, Japan., Karayama M; Second Division, Department of Internal Medicine, Hamamatsu University School of Medicine, 1-20-1 Handayama Higashiku, Hamamatsu, 431-3192, Japan., Furuhashi K; Second Division, Department of Internal Medicine, Hamamatsu University School of Medicine, 1-20-1 Handayama Higashiku, Hamamatsu, 431-3192, Japan., Enomoto N; Second Division, Department of Internal Medicine, Hamamatsu University School of Medicine, 1-20-1 Handayama Higashiku, Hamamatsu, 431-3192, Japan., Fujisawa T; Second Division, Department of Internal Medicine, Hamamatsu University School of Medicine, 1-20-1 Handayama Higashiku, Hamamatsu, 431-3192, Japan., Inui N; Second Division, Department of Internal Medicine, Hamamatsu University School of Medicine, 1-20-1 Handayama Higashiku, Hamamatsu, 431-3192, Japan.; Department of Clinical Pharmacology and Therapeutics, Hamamatsu University School of Medicine, 1-20-1 Handayama Higashiku, Hamamatsu, 431-3192, Japan., Suda T; Second Division, Department of Internal Medicine, Hamamatsu University School of Medicine, 1-20-1 Handayama Higashiku, Hamamatsu, 431-3192, Japan.
Publikováno v:
Respiratory research [Respir Res] 2024 Jul 31; Vol. 25 (1), pp. 293. Date of Electronic Publication: 2024 Jul 31.
Autor:
Fuster-Martínez I; Departamento de Farmacología, Universitat de València, Valencia 46010, Spain; FISABIO (Fundación para el Fomento de la Investigación Sanitaria y Biomédica de la Comunidad Valenciana), Valencia 46020, Spain. Electronic address: Isabel.Fuster-Martinez@uv.es., Calatayud S; Departamento de Farmacología, Universitat de València, Valencia 46010, Spain; CIBERehd (Centro de Investigación Biomédica en Red - Enfermedades Hepáticas y Digestivas), Spain. Electronic address: sara.calatayud@uv.es.
Publikováno v:
Pharmacological research [Pharmacol Res] 2024 Jul; Vol. 205, pp. 107245. Date of Electronic Publication: 2024 May 29.